Rhinitis, Allergic, Perennial News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

How to Prevent the 2018 Allergy Season From Getting the Best of You - Allure Magazine



Allure Magazine
 
How to Prevent the 2018 Allergy Season From Getting the Best of You 
Allure Magazine
Darria Long Gillespie, a clinical assistant professor at the University of Tennessee College of Medicine and head of clinical strategy at Sharecare, explains that seasonal allergies are only present during peak pollination times of specific allergens ...

 


Global Perennial Allergic Rhinitis Drug market to grow as Global Perennial Allergic Rhinitis Drug heats up - NB Post Gazette



Version of Event
 
Global Perennial Allergic Rhinitis Drug market to grow as Global Perennial Allergic Rhinitis Drug heats up 
NB Post Gazette
Questale released a detailed assessment of trends in Global Perennial Allergic Rhinitis Drug market. The research report includes diverse topics like total market size, key market drivers, challenges, growth opportunities, key players etc. We have also ...
Perennial Allergic Rhinitis Drug Market Clinical Analysis 2018 to 2025 Version of Event
Global Perennial Allergic Rhinitis Drug Market 2018- Faes Farma, SA, Glenmark Pharmaceuticals Ltd., Hisamitsu ... Observer of Press

all 5 news articles » 


Global Perennial Allergic Rhinitis Drug market Research Report Released with growth, latest trends & forecasts till 2022 - Tokenfolks (press release)



Global Perennial Allergic Rhinitis Drug market Research Report Released with growth, latest trends & forecasts till 2022 
Tokenfolks (press release)
Questale has just released a comprehensive market research report for Global Perennial Allergic Rhinitis Drug Market. This report focuses on top players in global market, with production, price, revenue and market share for each manufacturer, covering ...

and more » 


Allergic Rhinitis Market to Achieve $ 15 Billion Revenue at CAGR of ... - Medgadget (blog)



Medgadget (blog)
 
Allergic Rhinitis Market to Achieve $ 15 Billion Revenue at CAGR of ... 
Medgadget (blog)
The Allergic Rhinitis Market report provide past and estimated future revenue of the market's segments and sub-segments with respect to four main geographi.
Allergic Rhinitis Market is Likely to Witness a Healthy CAGR Growth ... satPRnews (press release)

all 2 news articles » 


Global Perennial Allergic Rhinitis Drug Market Attractiveness, Competitive Landscape and Key Players - Newsient (blog)



Global Perennial Allergic Rhinitis Drug Market Attractiveness, Competitive Landscape and Key Players 
Newsient (blog)
Questale published a new in-depth industry research that focuses on Global Perennial Allergic Rhinitis Drug market, delivers detailed analysis of market and future prospects of Global Perennial Allergic Rhinitis Drug market. The critical and ...

and more » 


Hit by slump in US sales, Glenmark Q3 net profit drops 78% to Rs ... - Moneycontrol.com



Moneycontrol.com
 
Hit by slump in US sales, Glenmark Q3 net profit drops 78% to Rs ... 
Moneycontrol.com
Glenmark's marketing portfolio through December 31, 2017 consists of 130 generic products authorised for distribution in the US market.

and more » 


Dear Dr Nina: My daughter seems to have a permanent sniffle - Independent.ie



Independent.ie
 
Dear Dr Nina: My daughter seems to have a permanent sniffle 
Independent.ie
Antihistamines reduce the body's allergic response, helping to limit the congestion, swelling and nasal drip associated with rhinitis. It is preferable to use those that are less sedating by day, but an older sedating one may have benefits if taken at ...

 


Glenmark: Glenmark readies specialty, innovative pipeline as ... - Economic Times



Economic Times
 
Glenmark: Glenmark readies specialty, innovative pipeline as ... 
Economic Times
MUMBAI: Worrying signs continue to emanate from the US for Indian drug makers as Glenmark, close after Sun Pharma's US subsidiary Taro, reported a sharp 40 per cent drop in sales to $113.7 million (Rs 735.8 crore) for the third quarter of FY2018. While ...

and more » 


Glenmark Pharmaceuticals Ltd announces Q3 FY17-18 results - Equity Bulls



Business Today
 
Glenmark Pharmaceuticals Ltd announces Q3 FY17-18 results 
Equity Bulls
The India business rebounded and has shown good sales growth due to improvement in the overall demand environment." said Glenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals Limited. He further added, "We reported positive results of Ryaltris ...
Glenmark consolidated net dips by 78%, scrip touches yearly low level pharmabiz.com
Glenmark Pharma slumps after disappointing Q3 numbers Business Standard

all 18 news articles » 


Allergic Rhinitis Drugs Market Dynamics, Comprehensive Analysis ... - satPRnews (press release)



Allergic Rhinitis Drugs Market Dynamics, Comprehensive Analysis ... 
satPRnews (press release)
Allergic Rhinitis Drugs Market report provides complete evaluation for those who are looking for Business expand in various regions, manufacturers, New entrants in the industry, Professional organisation/solutions providers, Government bodies ...

and more »